caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1508861188

Paul LoefflerM.D.

PRACTICEEAR, NOSE & THROAT ASSOCIATES OF CORPUS CHRISTISee all providers at this practice →
OtolaryngologyCorpus Christi, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,302
Unique beneficiaries
—
Total services
3,688
Distinct HCPCS
18
Medicare payment
$115K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 668 Otolaryngology providers in TX — top quintile (cohort median 967).
REFERRAL NETWORK

Where Paul Loeffler's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Clinical Pathology Laboratories, Inc.
Clinical Laboratory · Austin, TX
72145
NORTH BAY GENERAL HOSPITAL, INC.3349
CBSH,LLC2789
Michael Lovoi
Internal Medicine · Corpus Christi, TX
1647
Patrick Elvin
Diagnostic Radiology · Fort Worth, TX
1318
BAY AREA HEALTHCARE GROUP, LTD.1317
BRACKIN, JACK1235
Michael Mintz
Otolaryngology · Corpus Christi, TX
1132
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
1,475
Beneficiaries
—
Total drug cost
$62K
Distinct drugs
13
Brand share
35.1%
Top prescribed drugs
Levothyroxine Sodium324 claims
Famotidine297 claims
Levothyroxine Sodium269 claims
Azelastine/Fluticasone175 claims
Mupirocin101 claims
QUALITY · MIPS · 2024
Final MIPS score
75.0
Quality
0.0
Cost
0.0
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
0.00%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$273
Payment records
7
By payment type
Food and Beverage$273